Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL131930 | 0.86 | — | — | |
| Water SCHEMBL955956 | 0.84 | — | — | |
| Water SCHEMBL421187 | 0.84 | — | — | |
| SCHEMBL49152 | 0.78 | CA12 (0.39) | CA12CA7CA14SMN1; SMN2PKM | |
| SCHEMBL29926166 | 0.78 | CA12 (0.39) | CA12CA7CA14SMN1; SMN2PKM | |
| SCHEMBL28214258 | 0.77 | CHRM2 (0.36) | SMN1; SMN2LMNATSHRCYP3A4 | |
| SCHEMBL5492640 | 0.76 | CA12 (0.38) | CA12CA7CA14SMN1; SMN2PKM | |
| Water SCHEMBL730524 | 0.76 | CA12 (0.38) | CA12CA7CA14SMN1; SMN2PKM | |
| SCHEMBL4566523 | 0.76 | CA12 (0.38) | CA12CA7CA14SMN1; SMN2PKM | |
| SCHEMBL29027428 | 0.76 | CA12 (0.38) | CA12CA7CA14SMN1; SMN2PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108226531-A | A kind of beta 2-microglobulin detecting kit | 三诺生物传感股份有限公司 | 2018-06-29 | — | — | CN | claimed |
| CN-100538334-C | Phosphorus measuring reagent | SHANGHAI FOSUN PHARMACEUTICAL (CN) | 2009-09-09 | — | — | CN | claimed |
| US-20090155777-A1 | Methods for performing direct enzymatic reactions involving nucleic acid molecules | BIOQUEST, INC. (KR) | 2009-06-18 | — | — | US | claimed |
| EP-1874955-A4 | METHODS FOR PERFORMING DIRECT ENZYMATIC REACTIONS INVOLVING NUCLEIC ACID MOLECULES | BIOQUEST INC (KR) | 2009-05-06 | — | — | EP | claimed |
| CN-101128604-A | Methods for performing direct enzymatic reactions involving nucleic acid molecules | BIOQUEST INC (KR) | 2008-02-20 | — | — | CN | claimed |
| EP-1874955-A1 | METHODS FOR PERFORMING DIRECT ENZYMATIC REACTIONS INVOLVING NUCLEIC ACID MOLECULES | Bioquest, Inc. (KR) | 2008-01-09 | — | — | EP | claimed |
| CN-101063654-A | Phosphorus measuring reagent | SHANGHAI FOSUN PHARMACEUTICAL (CN) | 2007-10-31 | — | — | CN | claimed |
| WO-2006090987-A1 | METHODS FOR PERFORMING DIRECT ENZYMATIC REACTIONS INVOLVING NUCLEIC ACID MOLECULES | BIOQUEST, INC. (KR) | 2006-08-31 | — | — | WO | claimed |
| US-20040209015-A1 | Additives for use in print media to reduce bronzing | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2004-10-21 | — | — | US | claimed |
| US-6756467-B2 | POLYURETHANE SYSTEMS FOR USE AS ORTHOPAEDIC SPLINTING; VISCOSITY; SHELL LIFE | BSN MEDICAL, INC. | 2004-06-29 | — | — | US | claimed |
| CN-1100076-C | Curable composition | SMITH & NEPHEW (GB) | 2003-01-29 | — | — | CN | claimed |
| US-20020128421-A1 | Curable compositions | SHELVEY MICHAEL FRANCIS (GB) | 2002-09-12 | — | — | US | claimed |
| EP-0850256-B1 | CURABLE COMPOSITIONS | BSN MEDICAL INC (US) | 2002-07-17 | — | — | EP | claimed |
| US-6353077-B2 | A WATER CURABLE ISOCYANATE FUNCTIONALIZED PREPOLYMER AND A FIRST AND SECOND CATALYST COMPONENT CHARACTERIZED IN THAT THE FIRST AMINE CATALYST IS COVALENTLY BOUND-IN TO THE PREPOLYMER AND SECOND CATALYST IS NOT CHEMICALLY BOUND | BSN MEDICAL, INC. | 2002-03-05 | — | — | US | claimed |
| US-20010005744-A1 | CURABLE COMPOSITIONS | BSN MEDICAL, INC. | 2001-06-28 | — | — | US | claimed |
| CN-1202182-A | Curable compositions | SMITH & NEPHEW (GB) | 1998-12-16 | — | — | CN | claimed |
| EP-0850256-A1 | CURABLE COMPOSITIONS | Smith & Nephew plc (GB) | 1998-07-01 | — | — | EP | claimed |
| WO-1997010275-A1 | CURABLE COMPOSITIONS | SMITH & NEPHEW PLC (GB) | 1997-03-20 | — | — | WO | claimed |
| US-10301675-B2 | Compositions and methods for reducing inhibition of RT-PCR | BIO-RAD LABORATORIES, INC. (US) | 2019-05-28 | — | — | US | disclosed |
| EP-0673784-A2 | Recording sheets containing oxazole, isooxazole, oxazolidinone, oxazoline salts, morpholine, thiazole, thiazolidine, thiadiazole, and phenothiazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | disclosed |